牛牛AI助理已提取核心訊息
AbbVie Inc. officer Timothy Richmond is set to sell 75,680 common shares of the company, with an aggregate market value of approximately $13.38 million, on March 1, 2024. The shares to be sold were recently acquired through stock option exercises and performance shares. Specifically, Richmond acquired 45,700 shares on March 1, 2024, through stock option exercise, paying with cash, and 29,980 shares on February 28, 2024, as performance shares from the issuer. There is no recent sale history reported for the past three months. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on November 13, 2023.
AbbVie Inc. officer Timothy Richmond is set to sell 75,680 common shares of the company, with an aggregate market value of approximately $13.38 million, on March 1, 2024. The shares to be sold were recently acquired through stock option exercises and performance shares. Specifically, Richmond acquired 45,700 shares on March 1, 2024, through stock option exercise, paying with cash, and 29,980 shares on February 28, 2024, as performance shares from the issuer. There is no recent sale history reported for the past three months. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on November 13, 2023.
艾伯維公司高管蒂莫西·里士滿定於2024年3月1日出售該公司的75,680股普通股，總市值約爲1,338萬美元。擬出售的股票最近是通過股票期權行使和績效股票收購的。具體而言，里士滿於2024年3月1日通過行使股票期權以現金支付的方式收購了45,700股股票，並於2024年2月28日從發行人手中收購了29,980股作爲業績股。沒有報告過去三個月的近期銷售記錄。計劃出售的通知是在出售的同一天提交的，該交易的計劃已於2023年11月13日通過。
艾伯維公司高管蒂莫西·里士滿定於2024年3月1日出售該公司的75,680股普通股，總市值約爲1,338萬美元。擬出售的股票最近是通過股票期權行使和績效股票收購的。具體而言，里士滿於2024年3月1日通過行使股票期權以現金支付的方式收購了45,700股股票，並於2024年2月28日從發行人手中收購了29,980股作爲業績股。沒有報告過去三個月的近期銷售記錄。計劃出售的通知是在出售的同一天提交的，該交易的計劃已於2023年11月13日通過。
有用
沒用